Here are relevant reports on : employment-background-screening-market
-
Automotive Shredded Residue (ASR) Market by Application (Landfill, Energy recovery, Recycling), Composition, Technology ( Air classification, Optical sorting, Magnetic separation, Eddy current separation, Screening) and Region - Global Forecast to 2028
The automotive shredded residue (ASR) market is expected to grow from USD 1.1 billion in 2023 to USD 1.6 billion by 2028, at a CAGR of 6.6% during the forecast period. The key players in this market are Galloo (Belgium), MBA Polymers Inc. (US), PLANIC (Japan), Sims Limited (Australia), Axion Ltd (UK), SRW Metal Float GmbH (Germany), Machinex Industries Inc. (Canada), Wendt Corporation (US), Binder+Co. (Austria), CP Manufacturing Inc. (US), Tomra Systems ASA (Norway), BT-Wolfgang Binder GmbH (Austria), Agilyx (US), Steinert (Germany).
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Mental Health Apps Market by Platform (Android, iOS), Application (Depression, Meditation, Stress, Trauma), Function (Screening, Consultation, Prescription, Treatment, Monitoring, Coaching), End User (Provider, Patient, Employer) - Global Forecast to 2030
The Mental Health Apps market, valued at US$8.21 billion in 2024, stood at US$9.94 billion in 2025 and is projected to advance at a resilient CAGR of 18.0% from 2025 to 2030, culminating in a forecasted valuation of US$22.73 billion by the end of the period. The mental health apps market is growing rapidly, driven by advancements in digital technologies such as artificial intelligence, data analytics, and mobile health platforms.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Drug Screening Market by Offering [On-site Testing, Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)], Sample (Blood, Urine, Hair), Drug (Cannabis, Alcohol), End User (Workplace, Law, Hospitals) - Global Forecast to 2030
The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period. The market for drug screening is being fueled by growing workplace and clinical testing programs, an increased need for opioid/polysubstance monitoring, and an increased use of rapid point-of-care technologies and advanced confirmatory testing (LC MS/MS) systems.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
AI in Chemicals Market by Hardware (Accelerators, Processors, Memory, Network), Software (Dashboard & Analytics, Process Simulation, Laboratory Management, Chemical Property Prediction, Virtual Screening), Technology (ML, NLP) - Global Forecast to 2029
The global market for the AI in chemicals market is projected to reach USD 3.8 billion by 2029 at a CAGR of 39.2% during the forecast period. The major AI in chemicals providers include IBM (US), Microsoft (US), Schneider Electric (France), AWS (US), Google (US), SAP (Germany), NVIDIA (US), C3.ai (US), GE Vernova (US), Siemens (Germany), Hexagon (Sweden), Engie Impact (US), TrendMiner (Belgium), Xylem (US), NobleAI (US), Iktos (France), Kebotix (US), Uptime AI (US), Canvass AI (Canada), Nexocode (Poland), SandboxAQ (US), Deepmatter (England), Zapata AI (US), Citirne Informatics (US), Chemical.AI (China), Augury (Israel), Intellegens (UK), Ripik.AI (India), Tractian (US), Polymerize (Singapore), ScienceDesk (Germany), OptiSol Business Solutions (India), NuWater (Africa) and VROC (Australia). These companies have used both organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the AI in chemicals market.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Mining Machinery Market by Machinery Category (Crushing, Pulverizing & Screening, Mineral Processing, Surface & Underground), Application, Power Output, Electric & Hybrid Machinery (Mining Trucks, LHD), Battery Chemistry Region - Global Forecast to 2030
The mining machinery market is projected to reach USD 32.8 billion by 2030, at a CAGR of 4.1% during the forecast period. The mining machinery market is moderately fragmented. Caterpillar Inc (US), Komatsu Ltd (Japan), Sandvik AB (Sweden), Epiroc AB (Sweden), and Liebherr (Switzerland) are the key companies operating in the mining machinery market.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Preimplantation Genetic Testing Market by Product & Service (Reagents, Consumables, Instruments, Software), Technology (NGS, PCR, SNP, CGH), Procedure (Screening, Diagnosis), Application (Aneuploidy, HLA Typing), Type of cycle - Global Forecast to 2030
The global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028
The global theranostics market, valued at US$1.9 billion in 2022, stood at US$2.1 billion in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.3 billion by the end of the period. Increasing establishment of hospitals, rising focus on targeted therapies, and introduction of novel theranostic approaches are expected to drive the market during the forecast period.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Anti-money Laundering (AML) Market by Offering (Solutions (KYC/CDD & Sanctions Screening, Transaction Monitoring, Case Management & Reporting)), End User (Banks & Financial Institutes, Insurance, Gaming & Gambling), and Region - Global Forecast to 2030
The global AML market size is projected to grow from USD 4.13 billion in 2025 to USD 9.38 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 17.8% during the forecast period. LexisNexis (US), Oracle (US), FIS (US), Fiserv (US), Jumio (US), NICE Actimize (US), SAS Institute (US), GB Group PLC (UK), FICO (US), ACI Worldwide (US), Experian (Ireland), Wolters Kluwer (Netherlands), Transunion (US), ComplyAdvantage (UK), Friss (Netherlands), Nelito Systems (India), Comarch (Poland), Allsec Technologies (India), Dixtior (Portugal), Temenos (Switzerland), TCS (India), Featurespace (UK), Feedzai (Portugal), Napier AI (UK), Tier1 Financial Solutions (Canada), Finacus Solutions (India), SymphonyAI (US), IDMERIT (US), IMTF (Switzerland), Innovative Systems (US), Sedicii (Ireland), Trulioo (Canada), NameScan (Australia), DataVisor (US), and Gurucul (US) are the key players and other players in the AML market.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030
The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.
- Published: November 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
